Studies from University of Michigan Have Provided New Data on Major Depressive Disorder (Cost Sharing and Branded Antidepressant Initiation Among…
Studies from
By a
The news reporters obtained a quote from the research from the
According to the news reporters, the research concluded: "Results suggest that narrowing the gap in cost sharing between branded and generic medications following a trial of a generic agent might improve access to second-line treatment in MDD."
For more information on this research see: Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics.
Our news correspondents report that additional information may be obtained by contacting J.D. Buxbaum,
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
Research from Columbia Business School Measures Impact of New Cancer Drugs, Finds Most Significant Reduction in Mortality Rates 5-10 Years After…
Argo Group International Holdings, Ltd. Files SEC Form 8-K, Current Report: (Apr. 23, 2018)
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News